Covid-19 Variants That Have Spread in Indonesia

Monday, 15 November 2021 – 18:17 GMT+7
Minister of Health Budi Gunadi Sadikin / Credit: Ricardo, JPNN

jpnn.com, JAKARTA - In a number of countries, new variants of Covid-19 have emerged. Indonesia is no exception.

Minister of Health Budi Gunadi Sadikin, however, believed that Covid-19 vaccines available in Indonesia were still effective enough to deal with new variants of the virus.

ALSO SEE: 5,000 Doses of AstraZeneca Vaccine in NTT Expired

"So far, if there is a variant of the virus that enters the body, Insya Allah [God willing], the immunity that has been formed should still be sufficient to cope," Budi told the press at the Presidential Office in Jakarta, Monday (15/11), after attending a limited meeting to evaluate the implementation of community restrictions with President Joko Widodo.

Budi said that currently, various Covid-19 variants had spread in Indonesia.

ALSO SEE: 125 Million Indonesians Have Received First Dose of Covid-19 Vaccine

"Indeed, the Delta variant, with the code B.1.617.2, already has children, namely AY.4, AY.23, AY.24. Well, those in Indonesia are mostly the sub-variants of AY.23 and AY.24. There is also the granchild of AY.4, namely AY.4.2, which is now widely spread in England, also called the New Delta variant," he said.

He said the variants had similar genetic mutations to the parent virus.

ALSO SEE: Covid-19 Delta Variant Spreads to 11 Provinces in China

"Well, in Indonesia, [...] AY.4.2 doesn't exist yet. All Delta variants, their children, their sub-variants, their grandchildren have similar genetic mutations," said Budi.

The Delta variant of the corona virus, AY.4.2, is said to be the cause of the increase in Covid-19 cases by up to 10 percent in the UK and a number of European countries.

Meanwhile, the AY.23 variant is widely spread in Singapore.

ADVERTISING
ADVERTISING

In Indonesia, there are 10 types of Covid-19 vaccines available, namely Sinovac, AstraZeneca, Sinopharm, Moderna, Pfizer, Novavax, Johnson & Johnson, Biofarma, Cansino, and Zifivax vaccines.

Data from the Ministry of Health as of November 15, 2021, recorded that there had been 130.6 million people receiving the first dose of Covid-19 vaccine, or 62.72 percent of the target, while the second dose had been given to as many as 84.6 people.

Meanwhile, the third dose of vaccine has been given to 1.2 million health workers. (antara/mcr20/jpnn)

This news has been broadcast on JPNN.com with the title: Inilah Beberapa Varian COVID-19 yang Sudah Menyebar di Indonesia